Data as of Sep 13, 2026. Both funds on the fields they both publish, from the same sources.
IJT vs XLV: how they differ
IJT and XLV hold 0% of their weight in the same names, and XLV returned more over the year.
iShares S&P Small-Cap 600 Growth ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, IJT and XLV hold 0% of their money in the same securities at the same weight.
| Only in IJT | Only in XLV |
|---|---|
| CORCEPT THERAPEUTICS 1.29% | ELI LILLY + CO 14.87% |
| VIASAT INC 1.19% | JOHNSON + JOHNSON 10.73% |
| BRINKER INTERNATIONAL INC 1.09% | ABBVIE INC 7.54% |
| PROTAGONIST THERAPEUTICS 1.03% | MERCK + CO. INC. 5.98% |
| FORMFACTOR INC 1.03% | UNITEDHEALTH GROUP INC 5.90% |
| RYMAN HOSPITALITY PROPERTIES REIT 0.98% | THERMO FISHER SCIENTIFIC INC 3.75% |
| ALKERMES 0.91% | AMGEN INC 3.46% |
| STONEX GROUP INC 0.87% | ABBOTT LABORATORIES 3.01% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Sep 10, 2026.
| IJT iShares S&P Small-Cap 600 Growth ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | State Street |
| What it is | S&P Small-Cap 600 Growth | Health care |
| Total return, 1 year | +17.6% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +0.1 pts | +2.9 pts |
| Expense ratio | 0.18% | 0.08% |
| Already in the S&P 500 | 0.0% | 100.0% |
| Holdings | 355 | 63 |
IJT in plain words
IJT is an index equity fund tracking the S&P Small-Cap 600 Growth. Over the year to Sep 11, 2026 it returned +17.6% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.18% a year. By its holdings filed for Sep 10, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 355 positions, with the top ten at 10.1%. It sat 7.0% below its high of Aug 4, 2026 on Sep 11, 2026.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Sep 10, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 63 positions, with the top ten at 60.9%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, IJT or XLV?
- In the year to Sep 13, 2026, with distributions reinvested, IJT returned +17.6% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, IJT or XLV?
- IJT charges 0.18% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.
- How much do IJT and XLV overlap with the S&P 500?
- By their latest filed holdings, 0% of IJT and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 0% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, IJT against XLV, data as of Sep 13, 2026. https://etfiq.com/compare/any/ijt-vs-xlv Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources